CUSIP No. 150937100 Page 1 of 26 Pages
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
------------------------
SCHEDULE 13D
(Rule 13d-101)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO
RULE 13d-2(a)
(Amendment No. 1)*
Centennial HealthCare Corporation
-----------------------------------------------------------------
(Name of Issuer)
Common Stock, $.01 par value
-----------------------------------------------------------------
(Title of Class of Securities)
150937100
-----------------------------------------------------------------
(CUSIP Number)
--------
* The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which would
alter disclosures in a prior cover page.
The information required on the remainder of this cover page shall not
be deemed to be "filed" for the purpose of Section 18 of the Securities and
Exchange Act of 1934 or otherwise subject to the liabilities of that section of
the Act but shall be subject to all other provisions of the Act (however, see
the Notes).
<PAGE>
CUSIP No. 150937100 Page 2 of 26 Pages
Lawrence B. Sorrel William J. Hewitt, Esq.
Welsh, Carson, Anderson Reboul, MacMurray, Hewitt,
& Stowe Maynard & Kristol
320 Park Avenue 45 Rockefeller Plaza
New York, NY 10022 New York, NY 10111
Tel. (212) 893-9500 Tel. (212) 841-5700
Daryl R. Griswold, Esq.
Centennial HealthCare Corporation
400 Perimeter Center Terrace
Suite 650
Atlanta, GA 30346
Tel. (770) 698-9040
-----------------------------------------------------------------
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
April 2, 1999
-----------------------------------------------------------------
(Date of Event Which Requires Filing of This Statement
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition that is the subject of this Schedule 13D, and is filing this
schedule because of Rule 13d- 1(e), 13d-1(f) or 13d-1(g), check the following
box: [ ].
<PAGE>
CUSIP No. 150937100 Page 3 of 26 Pages
- -----------------------------------------------------------------
1) Names of Reporting Persons Welsh, Carson,
I.R.S. Identification Anderson &
Nos. of Above Persons (ENTITIES ONLY) Stowe VIII, L.P.
- -----------------------------------------------------------------
2) Check the Appropriate Box (a) [ ]
if a Member of a Group (b) [ ]
- -----------------------------------------------------------------
3) SEC Use Only
- -----------------------------------------------------------------
4) Source of Funds Not Applicable
- -----------------------------------------------------------------
5) Check Box if Disclosure of Not Applicable
Legal Proceedings is
Required Pursuant to
Item 2(d) or 2(e)
- -----------------------------------------------------------------
6) Citizenship or Place Delaware
of Organization
- -----------------------------------------------------------------
Number of 7) Sole Voting -0-
Shares Beneficially Power
Owned by Each
Reporting Person ________________________________________
With: 8) Shared Voting
Power -0-
----------------------------------------
9) Sole Disposi- -0-
tive Power
----------------------------------------
10) Shared Dis-
positive Power -0-
----------------------------------------
11) Aggregate Amount Beneficially -0-
Owned by Each Reporting Person
- -----------------------------------------------------------------
12) Check Box if the Aggregate
Amount in Row (11) [ ]
Excludes Certain Shares
- -----------------------------------------------------------------
13) Percent of Class
Represented by -0-
Amount in Row (11)
- -----------------------------------------------------------------
14) Type of Reporting
Person PN
<PAGE>
CUSIP No. 150937100 Page 4 of 26 Pages
- -----------------------------------------------------------------
1) Name of Reporting Person WCAS VIII
S.S. or I.R.S. Identification Associates LLC
No. of Above Person
- -----------------------------------------------------------------
2) Check the Appropriate Box (a) [ ]
if a Member of a Group (b) [ ]
- -----------------------------------------------------------------
3) SEC Use Only
- -----------------------------------------------------------------
4) Source of Funds Not Applicable
- -----------------------------------------------------------------
5) Check if Disclosure of Not Applicable
Legal Proceedings is
Required Pursuant to
Item 2(d) or 2(e)
- -----------------------------------------------------------------
6) Citizenship or Place Delaware
of Organization
- -----------------------------------------------------------------
Number of 7) Sole Voting -0-
Shares Beneficially Power
Owned by Each
Reporting Person ________________________________________
With: 8) Shared Voting
Power -0-
----------------------------------------
9) Sole Disposi- -0-
tive Power
----------------------------------------
10) Shared Dis-
positive Power -0-
----------------------------------------
11) Aggregate Amount Beneficially -0-
Owned by Each Reporting Person
- -----------------------------------------------------------------
12) Check if the Aggregate
Amount in Row (11) [ ]
Excludes Certain Shares
- -----------------------------------------------------------------
13) Percent of Class
Represented by -0-
Amount in Row (11)
- -----------------------------------------------------------------
14) Type of Reporting
Person OO
<PAGE>
CUSIP No. 150937100 Page 5 of 26 Pages
- -----------------------------------------------------------------
1) Names of Reporting Persons WCAS Capital
I.R.S. Identification Partners III, L.P.
Nos. of Above Persons (ENTITIES ONLY)
- -----------------------------------------------------------------
2) Check the Appropriate Box (a) [ ]
if a Member of a Group (b) [ ]
- -----------------------------------------------------------------
3) SEC Use Only
- -----------------------------------------------------------------
4) Source of Funds Not Applicable
- -----------------------------------------------------------------
5) Check Box if Disclosure of Not Applicable
Legal Proceedings is
Required Pursuant to
Item 2(d) or 2(e)
- -----------------------------------------------------------------
6) Citizenship or Place Delaware
of Organization
- -----------------------------------------------------------------
Number of Shares 7) Sole Voting -0-
Beneficially Power
Owned by Each
Reporting Person
With: ________________________________________
8) Shared Voting
Power -0-
----------------------------------------
9) Sole Disposi- -0-
tive Power
----------------------------------------
10) Shared Dis-
positive Power -0-
----------------------------------------
11) Aggregate Amount Beneficially -0-
Owned by Each Reporting Person
- -----------------------------------------------------------------
12) Check Box if the Aggregate
Amount in Row (11) [ ]
Excludes Certain Shares
- -----------------------------------------------------------------
13) Percent of Class
Represented by -0-
Amount in Row (11)
- -----------------------------------------------------------------
14) Type of Reporting
Person PN
<PAGE>
CUSIP No. 150937100 Page 6 of 26 Pages
- -----------------------------------------------------------------
1) Name of Reporting Person WCAS CP III
S.S. or I.R.S. Identification Associates L.L.C.
No. of Above Person
- -----------------------------------------------------------------
2) Check the Appropriate Box (a) [ ]
if a Member of a Group (b) [ ]
- -----------------------------------------------------------------
3) SEC Use Only
- -----------------------------------------------------------------
4) Source of Funds Not Applicable
- ----------------------------------------------------------------
5) Check if Disclosure of Not Applicable
Legal Proceedings is
Required Pursuant to
Item 2(d) or 2(e)
- -----------------------------------------------------------------
6) Citizenship or Place Delaware
of Organization
- -----------------------------------------------------------------
Number of Shares 7) Sole Voting -0-
Beneficially Power
Owned by Each
Reporting Person
With: ________________________________________
8) Shared Voting
Power -0-
----------------------------------------
9) Sole Disposi- -0-
tive Power
----------------------------------------
10) Shared Dis-
positive Power -0-
----------------------------------------
11) Aggregate Amount Beneficially -0-
Owned by Each Reporting Person
- -----------------------------------------------------------------
12) Check if the Aggregate
Amount in Row (11) [ ]
Excludes Certain Shares
- -----------------------------------------------------------------
13) Percent of Class
Represented by -0-
Amount in Row (11)
- -----------------------------------------------------------------
14) Type of Reporting
Person OO
<PAGE>
CUSIP No. 150937100 Page 7 of 26 Pages
- -------------------------------------------------------------
1) Names of Reporting Persons Welsh, Carson,
I.R.S. Identification Anderson & Stowe
Nos. of Above Persons (ENTITIES ONLY) VI, L.P.
- ----------------------------------------------------------------
2) Check the Appropriate Box (a) [ ]
if a Member of a Group (b) [ ]
- -----------------------------------------------------------------
3) SEC Use Only
- -----------------------------------------------------------------
4) Source of Funds WC
- -----------------------------------------------------------------
5) Check Box if Disclosure of Not Applicable
Legal Proceedings is
Required Pursuant to
Item 2(d) or 2(e)
- -----------------------------------------------------------------
6) Citizenship or Place Delaware
of Organization
- -----------------------------------------------------------------
Number of 7) Sole Voting 2,520,193 shares of
Shares Beneficially Power Common Stock, $.01
Owned by Each par value ("Common
Reporting Person Stock")
With:
8) Shared Voting
Power -0-
----------------------------------------
9) Sole Disposi- 2,520,193 shares of
tive Power Common Stock
----------------------------------------
10) Shared Dis-
positive Power -0-
----------------------------------------
11) Aggregate Amount Beneficially 2,520,193 shares of
Owned by Each Reporting Person Common Stock
- -----------------------------------------------------------------
12) Check Box if the Aggregate
Amount in Row (11) [ ]
Excludes Certain Shares
- -----------------------------------------------------------------
13) Percent of Class
Represented by 21.1%
Amount in Row (11)
- -----------------------------------------------------------------
14) Type of Reporting
Person PN
<PAGE>
CUSIP No. 150937100 Page 8 of 26 Pages
- --------------------------------------------------------------
1) Name of Reporting Person WCAS VI Partners, L.P.
S.S. or I.R.S. Identification
No. of Above Person
- -----------------------------------------------------------------
2) Check the Appropriate Box (a) [ ]
if a Member of a Group (b) [ ]
- -----------------------------------------------------------------
3) SEC Use Only
- -----------------------------------------------------------------
4) Source of Funds Not Applicable
- -----------------------------------------------------------------
5) Check if Disclosure of Not Applicable
Legal Proceedings is
Required Pursuant to
Item 2(d) or 2(e)
- -----------------------------------------------------------------
6) Citizenship or Place Delaware
of Organization
- -----------------------------------------------------------------
\Number of 7) Sole Voting 2,520,193 shares of
Shares Beneficially Power Common Stock
Owned by Each
Reporting Person
With: ________________________________________
8) Shared Voting
Power -0-
---------------------------------------
9) Sole Disposi- 2,520,193 shares of
tive Power Common Stock
----------------------------------------
10) Shared Dis-
positive Power -0-
----------------------------------------
11) Aggregate Amount Beneficially 2,520,193 shares of
Owned by Each Reporting Person Common Stock
- -----------------------------------------------------------------
12) Check if the Aggregate
Amount in Row (11) [ ]
Excludes Certain Shares
- -----------------------------------------------------------------
13) Percent of Class
Represented by 21.1%
Amount in Row (11)
- -----------------------------------------------------------------
14) Type of Reporting
Person PN
- -----------------------------------------------------------------
<PAGE>
CUSIP No. 150937100 Page 9 of 26 Pages
1) Names of Reporting Persons WCAS Capital
I.R.S. Identification Partners II, L.P.
Nos. of Above Persons (ENTITIES ONLY)
- -----------------------------------------------------------------
2) Check the Appropriate Box (a) [ ]
if a Member of a Group (b) [ ]
- -----------------------------------------------------------------
3) SEC Use Only
- -----------------------------------------------------------------
4) Source of Funds WC
- -----------------------------------------------------------------
5) Check Box if Disclosure of Not Applicable
Legal Proceedings is
Required Pursuant to
Item 2(d) or 2(e)
- -----------------------------------------------------------------
6) Citizenship or Place Delaware
of Organization
- -----------------------------------------------------------------
Number of Shares 7) Sole Voting 246,896 shares of
Beneficially Power Common Stock
Owned by Each
Reporting Person
With: ________________________________________
8) Shared Voting
Power -0-
----------------------------------------
9) Sole Disposi- 246,896 shares of
tive Power Common Stock
----------------------------------------
10) Shared Dis-
positive Power -0-
----------------------------------------
11) Aggregate Amount Beneficially 246,896 shares of
Owned by Each Reporting Person Common Stock
- -----------------------------------------------------------------
12) Check Box if the Aggregate
Amount in Row (11) [ ]
Excludes Certain Shares
- -----------------------------------------------------------------
13) Percent of Class
Represented by 2.1%
Amount in Row (11)
- -----------------------------------------------------------------
14) Type of Reporting
Person PN
<PAGE>
CUSIP No. 150937100 Page 10 of 26 Pages
- -----------------------------------------------------------------
1) Name of Reporting Person WCAS CP II
S.S. or I.R.S. Identification Partners
No. of Above Person
- -----------------------------------------------------------------
2) Check the Appropriate Box (a) [ ]
if a Member of a Group (b) [ ]
- -----------------------------------------------------------------
3) SEC Use Only
- -----------------------------------------------------------------
4) Source of Funds Not Applicable
- -----------------------------------------------------------------
5) Check if Disclosure of Not Applicable
Legal Proceedings is
Required Pursuant to
Item 2(d) or 2(e)
- -----------------------------------------------------------------
6) Citizenship or Place New Jersey
of Organization
- -----------------------------------------------------------------
Number of Shares 7) Sole Voting 246,896 shares of
Beneficially Power Common Stock
Owned by Each
Reporting Person
With: ________________________________________
8) Shared Voting
Power -0-
----------------------------------------
9) Sole Disposi- 246,896 shares of
tive Power Common Stock
----------------------------------------
10) Shared Dis-
positive Power -0-
----------------------------------------
11) Aggregate Amount Beneficially 246,896 shares of
Owned by Each Reporting Person Common Stock
- -----------------------------------------------------------------
12) Check if the Aggregate
Amount in Row (11) [ ]
Excludes Certain Shares
- -----------------------------------------------------------------
13) Percent of Class
Represented by 2.1%
Amount in Row (11)
- -----------------------------------------------------------------
14) Type of Reporting
Person PN
<PAGE>
CUSIP No. 150937100 Page 11 of 26 Pages
- ---------------------------------------------------------------
1) Names of Reporting Persons WCAS Healthcare
I.R.S. Identification Partners, L.P.
Nos. of Above Persons (ENTITIES ONLY)
- -----------------------------------------------------------------
2) Check the Appropriate Box (a) [ ]
if a Member of a Group (b) [ ]
- -----------------------------------------------------------------
3) SEC Use Only
- -----------------------------------------------------------------
4) Source of Funds WC
- ----------------------------------------------------------------
5) Check Box if Disclosure of Not Applicable
Legal Proceedings is
Required Pursuant to
Item 2(d) or 2(e)
- -----------------------------------------------------------------
6) Citizenship or Place Delaware
of Organization
- -----------------------------------------------------------------
Number of Shares 7) Sole Voting 81,384 shares of
Beneficially Power Common Stock
Owned by Each
Reporting Person
With:
----------------------------------------
8) Shared Voting
Power -0-
----------------------------------------
9) Sole Disposi- 81,384 shares of
tive Power Common Stock
----------------------------------------
10) Shared Dis-
positive Power -0-
----------------------------------------
11) Aggregate Amount Beneficially 81,384 shares of
Owned by Each Reporting Person Common Stock
- -----------------------------------------------------------------
12) Check Box if the Aggregate
Amount in Row (11) [ ]
Excludes Certain Shares
- -----------------------------------------------------------------
13) Percent of Class
Represented by 0.7%
Amount in Row (11)
- -----------------------------------------------------------------
14) Type of Reporting
Person PN
<PAGE>
CUSIP No. 150937100 Page 12 of 26 Pages
- -----------------------------------------------------------------
1) Name of Reporting Person WCAS HP Partners
S.S. or I.R.S. Identification
No. of Above Person
- -----------------------------------------------------------------
2) Check the Appropriate Box (a) [ ]
if a Member of a Group (b) [ ]
- -----------------------------------------------------------------
3) SEC Use Only
- -----------------------------------------------------------------
4) Source of Funds Not Applicable
- -----------------------------------------------------------------
5) Check if Disclosure of Not Applicable
Legal Proceedings is
Required Pursuant to
Item 2(d) or 2(e)
- -----------------------------------------------------------------
6) Citizenship or Place Delaware
of Organization
- -----------------------------------------------------------------
Number of Shares 7) Sole Voting 81,384 shares of
Beneficially Power Common Stock
Owned by Each
Reporting Person
With:
----------------------------------------
8) Shared Voting
Power -0-
----------------------------------------
9) Sole Disposi- 81,384 shares of
tive Power Common Stock
----------------------------------------
10) Shared Dis-
positive Power -0-
----------------------------------------
11) Aggregate Amount Beneficially 81,384 shares of
Owned by Each Reporting Person Common Stock
- -----------------------------------------------------------------
12) Check if the Aggregate
Amount in Row (11) [ ]
Excludes Certain Shares
- -----------------------------------------------------------------
13) Percent of Class
Represented by 0.7%
Amount in Row (11)
- -----------------------------------------------------------------
14) Type of Reporting
Person PN
- -----------------------------------------------------------------
<PAGE>
CUSIP No. 150937100 Page 13 of 26 Pages
1) Names of Reporting Persons J. Stephen Eaton
I.R.S. Identification
Nos. of Above Persons (ENTITIES ONLY)
- -----------------------------------------------------------------
2) Check the Appropriate Box (a) [ ]
if a Member of a Group (b) [ ]
- -----------------------------------------------------------------
3) SEC Use Only
- -----------------------------------------------------------------
4) Source of Funds PF
- -----------------------------------------------------------------
5) Check Box if Disclosure of Not Applicable
Legal Proceedings is
Required Pursuant to
Item 2(d) or 2(e)
- -----------------------------------------------------------------
6) Citizenship or Place U.S. Citizen
of Organization
- -----------------------------------------------------------------
Number of Shares 7) Sole Voting 1,213,077 (including
Beneficially Power 1,115,371 shares and
Owned by Each 97,706 shares issuable
Reporting Person upon exercise of options
With: currently exercisable
within 60 days,
respectively)
----------------------------------------
8) Shared Voting
Power -0-
----------------------------------------
9) Sole Disposi- 1,213,077
tive Power (including 1,115,371
shares and 97,706 shares
issuable upon exercise of
options currently
exercisable within 60
days, respectively)
----------------------------------------
10) Shared Dis-
positive Power -0-
----------------------------------------
11) Aggregate Amount Beneficially 1,213,077 (including
Owned by Each Reporting Person 1,115,371 shares and
97,706 shares issuable upon
exercise of options
currently exercisable
within 60 days,
respectively)
<PAGE>
CUSIP No. 150937100 Page 14 of 26 Pages
- -----------------------------------------------------------------
12) Check Box if the Aggregate
Amount in Row (11) [ ]
Excludes Certain Shares
- -----------------------------------------------------------------
13) Percent of Class
Represented by 10.1%
Amount in Row (11)
- -----------------------------------------------------------------
14) Type of Reporting
Person IN
<PAGE>
CUSIP No. 150937100 Page 15 of 26 Pages
- -----------------------------------------------------------------
1) Names of Reporting Persons Kent C. Fosha, Sr.
I.R.S. Identification
Nos. of Above Persons (ENTITIES ONLY)
- -----------------------------------------------------------------
2) Check the Appropriate Box (a) [ ]
if a Member of a Group (b) [ ]
- -----------------------------------------------------------------
3) SEC Use Only
- -----------------------------------------------------------------
4) Source of Funds PF
- -----------------------------------------------------------------
5) Check Box if Disclosure of Not Applicable
Legal Proceedings is
Required Pursuant to
Item 2(d) or 2(e)
- -----------------------------------------------------------------
6) Citizenship or Place U.S. Citizen
of Organization
- -----------------------------------------------------------------
Number of Shares 7) Sole Voting 53,949 (including
Beneficially Power 7,970 shares
Owned by Each and 45,979 shares
Reporting Person issuable upon exercise
With: of options currently
exercisable within 60
days, respectively)
----------------------------------------
8) Shared Voting
Power -0-
----------------------------------------
9) Sole Disposi- 53,949 (including
tive Power 7,970 shares and 45,979
shares issuable upon
exercise of options
currently exercisable
within 60 days,
respectively)
----------------------------------------
10) Shared Dis-
positive Power -0-
----------------------------------------
11) Aggregate Amount Beneficially 53,949 (including
Owned by Each Reporting Person 7,970 shares and 45,979
shares issuable upon
exercise of options
currently exercisable
within 60 days,
respectively)
<PAGE>
CUSIP No. 150937100 Page 16 of 26 Pages
- -----------------------------------------------------------------
12) Check Box if the Aggregate
Amount in Row (11) [ ]
Excludes Certain Shares
- -----------------------------------------------------------------
13) Percent of Class
Represented by 0.5%
Amount in Row (11)
- -----------------------------------------------------------------
14) Type of Reporting
Person IN
<PAGE>
CUSIP No. 150937100 Page 17 of 26 Pages
- -----------------------------------------------------------------
1) Names of Reporting Persons Alan C. Dahl
I.R.S. Identification
Nos. of Above Persons (ENTITIES ONLY)
- -----------------------------------------------------------------
2) Check the Appropriate Box (a) [ ]
if a Member of a Group (b) [ ]
- -----------------------------------------------------------------
3) SEC Use Only
- -----------------------------------------------------------------
4) Source of Funds PF
- -----------------------------------------------------------------
5) Check Box if Disclosure of Not Applicable
Legal Proceedings is
Required Pursuant to
Item 2(d) or 2(e)
- -----------------------------------------------------------------
6) Citizenship or Place U.S. Citizen
of Organization
- -----------------------------------------------------------------
Number of Shares 7) Sole Voting 93,976 (including
Beneficially Power 59,492 shares and
Owned by Each 34,484 shares issuable
Reporting Person upon exercise of options
With: currently exercisable
within 60 days,
respectively)
----------------------------------------
8) Shared Voting
Power -0-
----------------------------------------
9) Sole Disposi- 93,976 (including
tive Power 59,492 shares and 34,484
shares issuable upon
exercise of options
currently exercisable
within 60 days,
respectively)
----------------------------------------
10) Shared Dis-
positive Power -0-
----------------------------------------
11) Aggregate Amount Beneficially 93,976 (including
Owned by Each Reporting Person 59,492 shares and 34,484
shares issuable upon
exercise of options
currently exercisable
within 60 days,
respectively)
<PAGE>
CUSIP No. 150937100 Page 18 of 26 Pages
- -----------------------------------------------------------------
12) Check Box if the Aggregate
Amount in Row (11) [ ]
Excludes Certain Shares
- -----------------------------------------------------------------
13) Percent of Class
Represented by 0.8%
Amount in Row (11)
- -----------------------------------------------------------------
14) Type of Reporting
Person IN
<PAGE>
CUSIP No. 150937100 Page 19 of 26 Pages
- -----------------------------------------------------------------
1) Names of Reporting Persons Lawrence W. Lepley
I.R.S. Identification
Nos. of Above Persons (ENTITIES ONLY)
- -----------------------------------------------------------------
2) Check the Appropriate Box (a) [ ]
if a Member of a Group (b) [ ]
- -----------------------------------------------------------------
3) SEC Use Only
- -----------------------------------------------------------------
4) Source of Funds PF
- -----------------------------------------------------------------
5) Check Box if Disclosure of Not Applicable
Legal Proceedings is
Required Pursuant to
Item 2(d) or 2(e)
- -----------------------------------------------------------------
6) Citizenship or Place U.S. Citizen
of Organization
- -----------------------------------------------------------------
Number of Shares 7) Sole Voting 92,226 (including
Beneficially Power 83,225 shares and
Owned by Each 9,001 shares issuable
Reporting Person upon exercise of options
With: currently exercisable
within 60 days,
respectively)
----------------------------------------
8) Shared Voting
Power -0-
----------------------------------------
9) Sole Disposi- 92,226 (including
tive Power 83,225 shares and 9,001
shares issuable upon
exercise of options
currently exercisable
within 60 days,
respectively)
----------------------------------------
10) Shared Dis-
positive Power -0-
----------------------------------------
11) Aggregate Amount Beneficially 92,226 (including
Owned by Each Reporting Person 83,225 shares and 9,001
shares issuable upon
exercise of options
currently exercisable
within 60 days,
respectively)
<PAGE>
CUSIP No. 150937100 Page 20 of 26 Pages
- -----------------------------------------------------------------
12) Check Box if the Aggregate
Amount in Row (11) [ ]
Excludes Certain Shares
- -----------------------------------------------------------------
13) Percent of Class
Represented by 0.8%
Amount in Row (11)
- -----------------------------------------------------------------
14) Type of Reporting
Person IN
<PAGE>
CUSIP No. 150937100 Page 21 of 26 Pages
Amendment No. 1 to
Schedule 13D
------------
The items of the statement on Schedule 13D dated November 2, 1998
relating to the Common Stock, $.01 par value (the "Common Stock"), of Centennial
HealthCare Corporation, a Georgia corporation (the "Issuer"), which was filed by
a group consisting of Welsh, Carson, Anderson & Stowe VIII, L.P. ("WCAS VIII"),
WCAS VIII Associates LLC ("VIII Associates"), WCAS Capital Partner III, L.P.
("WCAS CP III"), WCAS CP III Associates L.L.C. ("CP III Associates"), Welsh,
Carson, Anderson & Stowe VI L.P. ("WCAS VI"), WCAS VI Partners, L.P. ("VI
Partners"), WCAS Capital Partners II, L.P., ("WCAS CP II"), WCAS CP II Partners
("WCAS CP II Partners"), WCAS Healthcare Partners, L.P. ("Heathcare Partners"),
WCAS HP Partners ("HP Partners"), J. Stephen Eaton, Kent C. Fosha, Sr., Alan C.
Dahl and Lawrence W. Lepley are hereby incorporated by reference, except as
amended and restated as set forth below.
Item 2. Identity and Background.
-----------------------
(a) Pursuant to Regulation 13D-G of the General Rules and Regulations
under the Securities Exchange Act of 1934, as amended (the "Act"), the
undersigned hereby file this statement on Schedule 13D on behalf of WCAS VIII,
VIII Associates, WCAS CP III, CP III Associates, Healthcare Partners, HP
Partners, WCAS VI, VI Partners, WCAS CP II, WCAS CP II Partners, J. Stephen
Eaton, Kent C. Fosha, Sr., Alan C. Dahl and Lawrence W. Lepley (hereinafter
collectively referred to as the "Reporting Persons").
The Reporting Persons made a single, joint filing on Schedule 13D on
November 2, 1998 (the "November Filing") because they could have been deemed, at
that time, to constitute a "group" within the meaning of Section 13(d)(3) of the
Act. An agreement among the Reporting Persons to file the November Filing as a
group was attached as Exhibit A to the November Filing. In the November Filing,
each Reporting Person disclaimed beneficial ownership of all shares of Common
Stock other than those reported therein as being owned by he or it. The
Reporting Persons believe that, as a result of the delivery of the Notice of
Termination (as defined in Item 6) on April 2, 1999, the group that may have
existed no longer exists.
<PAGE>
CUSIP No. 150937100 Page 22 of 26 Pages
Item 4. Purpose of Transaction.
----------------------
Each of the Reporting Persons has acquired securities of the Issuer
for investment purposes and will continue to review his or its investment in the
Issuer and reserves the right, based on such review, to acquire additional
securities of the Issuer, or to dispose of any or all of the securities
purchased by he or it, or otherwise change his or its intentions with respect to
his or its investments.
Item 6. Contracts, Arrangements, Understandings or
Relationships with Respect to Securities
of the Issuer.
------------------------------------------
On October 22, 1998, the Issuer entered into an Agreement and Plan of
Merger (the "Merger Agreement") with Centennial HealthCare Holdings Corporation
(f/k/a Cougar Holdings Corporation), a Delaware corporation (the "Parent"), and
Cougar Acquisition Corp., a Georgia corporation (the "Acquisition Sub"). The
Merger Agreement was incorporated by reference in the November Filing as Exhibit
B thereto, and any description thereof is qualified in its entirety by reference
thereto. The Parent is the sole shareholder of the Acquisition Sub. WCAS VIII
formed the Parent and the Acquisition Sub in order to facilitate the Merger
described below. The Merger Agreement provided for, among other things, the
acquisition of the Issuer by Parent pursuant to a merger of the Acquisition Sub
with and into the Issuer (the "Merger").
Pursuant to a Shareholders Agreement dated as of October 22, 1998 (the
"Shareholders Agreement") among the Parent, the Acquisition Sub, WCAS VI and
<PAGE>
CUSIP No. 150937100 Page 23 of 26 Pages
Messrs. Eaton, Fosha, Dahl and Lepley (collectively, the "Management Parties"),
the Management Parties agreed to contribute, prior to the Merger, to the Parent
not less than 505,000 shares of Common Stock in exchange for shares of the
Parent's common stock. Pursuant to the Shareholders Agreement, (i) WCAS VIII and
certain affiliated individuals agreed to purchase, prior to the Merger, for an
aggregate $100 million in cash, 50 million shares of the Parent's common stock
and (ii) WCAS CP III agreed to purchase, prior to the Merger, for an aggregate
of $100 million in cash, the Parent's subordinated notes in the face amount of
$100 million and 7,142,857 shares of the Parent's common stock. The Shareholders
Agreement was attached to the November Filing as Exhibit D thereto, and any
description thereof is qualified in its entirety by reference thereto.
Pursuant to the Shareholders Agreement, WCAS VI and each of the
Management Parties agreed to vote their shares of the Issuer (i) in favor of
adoption and approval of the Merger Agreement and the Merger and the approval of
the terms thereof and each of the other actions contemplated by the Merger
Agreement and the Shareholders Agreement and (ii) except as otherwise agreed to
in writing in advance by the Parent, against the following actions (other than
the Merger and the transactions contemplated by the Merger Agreement): (A) any
extraordinary corporate transaction, such as a merger, consolidation or other
business combination involving the Issuer or its subsidiaries; (B) a sale, lease
or transfer of a material amount of assets of the Issuer or its subsidiaries, or
a reorganization, recapitalization, dissolution or liquidation of the Issuer or
its subsidiaries; (C) (1) any change in a majority of the persons who constitute
the Board of Directors of the Issuer; (2) any material amendment of the Issuer's
Amended and Restated Articles of Incorporation or Amended and Restated By-laws;
or (3) any other action involving the Issuer or its subsidiaries which would
have had the effect of impeding, interfering with, delaying, postponing, or
impairing (A) the ability of the Issuer to consummate the Merger or (B) the
transaction contemplated by the Shareholders Agreement and the Merger Agreement.
Pursuant to the Shareholders Agreement, WCAS VI and each of the Management
Parties agreed not to enter into any agreement or understanding with any
person or entity prior to the termination of the Shareholders Agreement to vote
in any manner inconsistent therewith.
Pursuant to the Shareholders Agreement, each of the Management Parties
further agreed that while the Merger Agreement was in effect, and except as
contemplated by the Shareholders Agreement, not to (i) sell, transfer, pledge,
encumber, assign or otherwise dispose of, enforce or permit the execution of the
provisions of any redemption agreement with the Issuer or enter into any
<PAGE>
CUSIP No. 150937100 Page 24 of 26 Pages
contract, option or other arrangement or understanding with respect to or
consent to the offer for sale, sale, transfer, pledge, encumbrance, assignment
or other disposition of, any of its shares of the Issuer, or any shares of the
Issuer acquired after the date thereof, or any interest in any of the foregoing,
except to the Parent; (ii) grant any proxies or powers of attorney, deposit any
Shares of the Issuer into a voting trust or enter into a voting agreement with
respect to any such Shares, or any interest in any of the foregoing, except to
the Parent or the Acquisition Sub; or (iii) take any action that would have made
any representation or warranty of such Management Parties contained therein
untrue or incorrect or have the effect of preventing or disabling the Management
Parties from performing such Management Parties' obligations under the
Shareholders Agreement. By letter dated April 2, 1999, the Parent notified the
Issuer that the Merger Agreement was terminated and the Merger abandoned (the
"Notice of Termination"). Termination of the Merger Agreement terminates the
Shareholders Agreement.
<PAGE>
CUSIP No. 150937100 Page 25 of 26 Pages
Signature:
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
WELSH, CARSON, ANDERSON & STOWE VIII, L.P.
By: WCAS VIII Associates LLC, General
Partner
By /s/ Laura VanBuren
Managing Member
WCAS VIII ASSOCIATES LLC
By /s/ Laura VanBuren
Managing Member
WCAS CAPITAL PARTNERS III, L.P.
By: WCAS CP III Associates L.L.C., General
Partner
By /s/ Laura VanBuren
Managing Member
WCAS CP III ASSOCIATES L.L.C.
By /s/ Laura VanBuren
Managing Member
WCAS HEALTHCARE PARTNERS, L.P.
By: WCAS HP Partners, General Partner
By /s/ Laura VanBuren
Attorney-in-Fact
WCAS HP PARTNERS
By /s/ Laura VanBuren
Attorney-in-Fact
WCAS CAPITAL PARTNERS II, L.P.
By: WCAS CP II Partners, General Partner
By /s/ Laura VanBuren
General Partner
WCAS CP II PARTNERS
By /s/ Laura VanBuren
General Partner
WELSH, CARSON, ANDERSON & STOWE VI, L.P.
By: WCAS VI Partners, L.P., General Partner
By /s/ Laura VanBuren
General Partner
WCAS VI PARTNERS, L.P.
By /s/ Laura VanBuren
General Partners
<PAGE>
CUSIP No. 150937100 Page 26 of 26 Pages
/s/ J. Stephen Eaton
J. Stephen Eaton
/s/ Kent C. Fosha, Sr.
Kent C. Fosha, Sr.
/s/ Alan C. Dahl
Alan C. Dahl
/s/ Lawrence W. Lepley
Lawrence W. Lepley
Dated: April 13, 1999
